杭州市结核病患者耐药检测结果分析

doi:10.19485/j.cnki.issn2096-5087.2019.03.017

Preventive Medicine

2019, Vol. 31

Issue (3): 289-292 DOI: 10.19485/j.cnki.issn2096-5087.2019.03.017

Current Issue | Archive | Adv Search

Abstract
Figure/Table
References
Related Citation (15)

[1] World Health Organization.Global tuberculosis report[EB/OL].[2018-09-15].http://www.who.int/tb/publications/global_report/en/.
[2] 庞学文,李晓蓉,赵恩奕. 耐多药结核病经济负担及应对措施[J]. 职业与健康,2018,34(8):1140-1144.
[3] BOEHME C C,NABETA P,HILLEMANN D,et al.Rapid molecular detection of tuberculosis and rifampin resistance[J]. New England Journal of Medicine,2010,363(11):1005-1015.
[4] XU K,WANG S,WU J,et al.Performance of Biochip system in detecting drug resistant and multidrug-resistant tuberculosis using sputum collected from multiple clinical settings in Zhejiang,China[J]. Sci Rep,2018,8(1):10587.
[5] 全国第五次结核病流行病学抽样调查技术指导组,全国第五次结核病流行病学抽样调查办公室. 2010 年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志,2012,34(8):485-508.
[6] CHEN Y,ZHAO Y.Multidrug-resistant tuberculosis in rural China:lack of public awareness,unaffordable costs and poor clinical management[J]. BMJ Case Rep,2018(11):225794.
[7] PENG Y,CHEN S H,ZHANG L,et al.Multidrug-resistant tuberculsis burden among the new tuberculosis patients in Zhejiang Province:an observational study,2009-2013[J]. Chin Med J(Engl),2017,130(17):2021-2026.
[8] 赵雁林,逄宇. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015:1-260.
[9] 唐神结,肖和平. 《耐药结核病化学治疗指南》修订工作研讨会在京召开[J].中国防痨杂志,2015,37(5):421-469.
[10] 柳正卫,何海波,王晓萌,等. 浙江省第三次结核病耐药性监测结果分析[J]. 中华预防医学杂志,2011,45(2):171-173.
[11] LI Q,ZHAO G,WU L,et al.Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou,China[J]. Antimicrobial Resistance and Infection Control,2018, 7(1):61.
[12] 陈松华,王晓萌,柳正卫,等. 浙江省耐多药结核病例中二线耐药状况分析[J]. 中国预防医学杂志,2011,45(9):761-764.
[13] WU B,ZHANG L,LIU Z,et al.Drug-resistant tuberculosis in Zhejiang Province,China:an updated analysis of time trends,1999-2013[J]. Glob Health Action,2017,10(1):1293925.
[14] 何贵清,施伎蝉,吴联朋,等. 耐多药肺结核患者基线菌株二线抗结核药物耐药情况分析[J]. 中国现代医生,2018,56(15):84-87.
[15] 范大鹏,张艳,夏强,等. 2010—2011年杭州市636例肺结核患者耐药情况分析[J]. 中国防痨杂志,2012,34(11):750-752.
[16] World Health Organization. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs:policy guidance[EB/OL].(2017-11-21)[2018-09-15]. http://www.who.int/tb/publications/lpa-mdr-diagnostics/en.